|
||
Actress Angelina Jolie leaves Lancaster House after attending the G8 Foreign Ministers’ conference on April 11, 2013 in London. (OLI SCARFF / GETTY IMAGES) Angelina Jolie’s op-ed in The New York Times was big news yesterday. Jolie shared her family history of cancer, her own genetic mutation, and her choice to have prophylactic . . . → Read More: Celebrity Breasts and Corporate Gene Patents 
“The Choice.” By Mark E. Robson, MD, The Huffington Post. I must confess that I am very conflicted about adding to the river of words that have been written about Angelina Jolie’s decision to undergo a risk-reducing (preventive) mastectomy. She made a difficult choice, and has discussed that choice with power and grace, in the . . . → Read More: The Choice
“Why more women are choosing double mastectomies.” By Allison Gilbert, CNN. The number of women with early stage breast cancer who went on to remove both breasts (even though only one breast had cancer) increased by more than 150% between 1998 and 2003, according to a study presented by Dr. Kelly Hunt at the annual . . . → Read More: Why more women are choosing double mastectomies
“Angelina Jolie And The Rise of Preventive Mastectomies.” By Nancy Shute, NPR. Angelina Jolie just became part of a medical trend: More women are deciding to have their breasts removed to reduce the risk of cancer. Over the past decade, doctors have noticed a big increase in the number of women choosing prophylactic, or preventive, . . . → Read More: Angelina Jolie and the Rise of Preventive Mastectomies
“Jolie’s Disclosure of Preventive Mastectomy Highlights Dilemma.” By Denise Grady, The New York Times. One of the defining moments in the history of breast cancer occurred in 1974 when the first lady, Betty Ford, spoke openly about her mastectomy, lifting a veil of secrecy from the disease and ushering in a new era of breast . . . → Read More: Jolie’s Disclosure of Preventive Mastectomy Highlights Dilemma 
Barbara Brenner (1951-2013) Barbara Brenner was 41 when she was first diagnosed with breast cancer, a diagnosis that led the lawyer and activist to join the board of Breast Cancer Action, a grassroots advocacy organization in San Francisco started by women with breast cancer. A year later, she became the organization’s first full-time . . . → Read More: In Honor and Memory of Barbara Brenner 
On May 12, 2009, the ACLU and the Public Patent Foundation (PUBPAT) filed a lawsuit charging that patents on two human genes associated with breast and ovarian cancer, BRCA1 and BRCA2, are unconstitutional and invalid. On November 30, 2012, the Supreme Court agreed to hear argument on the patentability of human genes. The . . . → Read More: “Who Owns Your Body?” ACLU Video 
The Breast Cancer Consortium, Gathering Momentum The Breast Cancer Consortium formed in October 2012 with a group of professionals committed to research and social change. In the few months of our existence, we have already seen important change in the breast cancer landscape. The documentary, “Pink Ribbons Inc.” blazes the international and national trails, . . . → Read More: BCC Quarterly is Out! (2013 Issue 2)
“Why did Komen for the Cure give Nancy Brinker a 64 percent raise?” By Mary Elizabeth Williams, Salon.com. Komen, already under fire for shrinking contributions for breast cancer research, paid its CEO $684,000 last year. In 2012, the breast cancer organization ignited a firestorm by announcing it was pulling its funding for breast cancer screenings . . . → Read More: Why did Komen for the Cure give Nancy Brinker a 64 percent raise?
“Forget Pink-Remember Rose.” By Peggy Orenstein, Blog. There were a couple of things that got cut from my New York Times Magazine piece on breast cancer that I wish I could’ve squeezed in. One is kind of wonky, which is why it was dropped, but super important. It’s about data collection, based on a discussion . . . → Read More: Forget Pink–Remember Rose |
||
| Copyright © 2026 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||